cbdMD, Inc. (YCBD) stock
YCBDNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/3081% below fair value
$0.37+0.01 (+2.77%)
Close on Nov 18, 2026Market cap $4.19MP/E –Yield –
cbdMD revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
cbdMD's revenue for the twelve months ending Jun 30, 2026 was $20.93M, up 10.0% year over year. For fiscal 2025 it was $19.19M, down 1.5% from the year before. The highest annual figure on record is $44.48M in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $19.19M | -1.5% |
| FY2024 | Sep 30, 2024 | $19.48M | -19.3% |
| FY2023 | Sep 30, 2023 | $24.16M | -31.8% |
| FY2022 | Sep 30, 2022 | $35.40M | -20.4% |
| FY2021 | Sep 30, 2021 | $44.48M | +6.2% |
| FY2020 | Sep 30, 2020 | $41.88M | +77.1% |
| FY2019 | Sep 30, 2019 | $23.65M | +5051.8% |
| FY2018 | Sep 30, 2018 | $459.09K | -89.7% |
| FY2017 | Sep 30, 2017 | $4.47M | +120.3% |
| FY2016 | Sep 30, 2016 | $2.03M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $5.55M | +20.6% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $5.64M | +18.8% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $5.02M | -1.9% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $4.72M | +3.6% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $4.61M | -11.0% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $4.75M | +8.5% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $5.11M | -4.9% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $4.56M | -20.2% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $5.17M | -15.5% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $4.38M | -29.9% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $5.38M | -11.7% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $5.71M | -27.3% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $6.12M | -28.8% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $6.24M | -36.3% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $6.09M | -42.4% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $7.86M | -33.4% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $8.59M | -30.3% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $9.79M | -16.3% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $10.56M | -0.7% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $11.80M | +25.5% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $12.33M | +21.5% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $11.70M | +22.6% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $10.64M | +32.9% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $9.40M | +66.8% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $10.15M | +2079.2% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $9.54M | +556.8% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $8.01M | +150.3% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $5.64M | +83.0% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $465.69K | -32.3% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $1.45M | +34.6% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $3.20M | +79.0% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $3.08M | +118.7% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $687.76K | +244.2% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $1.08M | – |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $1.79M | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $1.41M | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $199.84K | – |
See a number that looks wrong?